Back to Menu
Leukemia is a malignant clonal disorder arising from hematopoietic stem or progenitor cells. Its hallmark is uncontrolled proliferation of leukemic cells in the bone marrow, which suppresses normal hematopoiesis and infiltrates other tissues, leading to anemia, bleeding, and infection.
1. Genetic factors
A family history may increase risk, and genetic susceptibility plays an important role.
2. Chemical exposure
Long-term exposure to benzene and related compounds can damage the hematopoietic system and increase leukemia risk.
3. Ionizing radiation
This includes therapeutic radiation and nuclear radiation exposure and is a well-established leukemia risk factor.
4. Viral infection
Epstein–Barr virus and human T-cell lymphotropic virus are associated with certain leukemia subtypes.
5. Immune dysfunction
Individuals with impaired immunity, such as post-transplant patients, may have a higher incidence of leukemia.
6. Hereditary disorders
Genetic conditions such as Down syndrome are associated with a markedly increased leukemia risk.
7. Drug-related factors
Certain chemotherapy agents, especially alkylating agents, may induce secondary leukemia.
1. Avoid risk factors
Reduce exposure to toxic chemicals and ionizing radiation, and use appropriate personal protection in occupational settings.
2. Healthy lifestyle
Maintain a balanced diet, exercise appropriately, stop smoking, limit alcohol, and support immune health.
3. Regular health examinations
Routine blood counts can help identify abnormal findings early, especially in high-risk individuals.
4. Rational medication use
Avoid unnecessary use of drugs that may damage the hematopoietic system and follow medical advice when taking medications.
5. Infection prevention
Maintain personal hygiene, reduce viral infection risk, and receive appropriate vaccinations in accordance with medical guidance.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that leukemia is a life-threatening malignant blood disorder with complex pathogenesis and major clinical impact. With medical advances, treatment has evolved from conventional chemotherapy to integrated approaches including targeted therapy, immunotherapy, and transplantation, substantially improving prognosis. Early diagnosis and standardized treatment are key to improving cure rates. MDT-based individualized treatment planning can maximize therapeutic benefit. Strengthening public awareness and preventive understanding remains highly important.
Leukemia is a malignant clonal disorder arising from hematopoietic stem or progenitor cells. Its hallmark is uncontrolled proliferation of leukemic cells in the bone marrow, which suppresses normal hematopoiesis and infiltrates other tissues, leading to anemia, bleeding, and infection.
1. Genetic factors
A family history may increase risk, and genetic susceptibility plays an important role.
2. Chemical exposure
Long-term exposure to benzene and related compounds can damage the hematopoietic system and increase leukemia risk.
3. Ionizing radiation
This includes therapeutic radiation and nuclear radiation exposure and is a well-established leukemia risk factor.
4. Viral infection
Epstein–Barr virus and human T-cell lymphotropic virus are associated with certain leukemia subtypes.
5. Immune dysfunction
Individuals with impaired immunity, such as post-transplant patients, may have a higher incidence of leukemia.
6. Hereditary disorders
Genetic conditions such as Down syndrome are associated with a markedly increased leukemia risk.
7. Drug-related factors
Certain chemotherapy agents, especially alkylating agents, may induce secondary leukemia.
1. Avoid risk factors
Reduce exposure to toxic chemicals and ionizing radiation, and use appropriate personal protection in occupational settings.
2. Healthy lifestyle
Maintain a balanced diet, exercise appropriately, stop smoking, limit alcohol, and support immune health.
3. Regular health examinations
Routine blood counts can help identify abnormal findings early, especially in high-risk individuals.
4. Rational medication use
Avoid unnecessary use of drugs that may damage the hematopoietic system and follow medical advice when taking medications.
5. Infection prevention
Maintain personal hygiene, reduce viral infection risk, and receive appropriate vaccinations in accordance with medical guidance.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that leukemia is a life-threatening malignant blood disorder with complex pathogenesis and major clinical impact. With medical advances, treatment has evolved from conventional chemotherapy to integrated approaches including targeted therapy, immunotherapy, and transplantation, substantially improving prognosis. Early diagnosis and standardized treatment are key to improving cure rates. MDT-based individualized treatment planning can maximize therapeutic benefit. Strengthening public awareness and preventive understanding remains highly important.